
Pramodini Medicare IPO
- Issue price
- ₹118
- Listing price
- ₹120
- +1.69%
- Current price
- ₹105.35
- -10.72%
- Subscribed
- 3.66x
- Issue size
- ₹69.04 Cr
- Listed on
- 19 Aug 2026
IPO timeline
- Opens12 AugWed
- Closes14 AugFri
- Allotment17 AugMon
- Refunds18 AugTue
- Demat credit18 AugTue
- Listing19 AugWed
Issue details
- Price band
- ₹110 – ₹118 per share
- Issue size
- ₹69.04 Cr
- Fresh issue
- Not available
- Offer for sale
- Not available
- Issue type
- Fresh capital cum OFS
- Face value
- ₹10 per share
- Lot size
- 1,200 shares
- Minimum investment
- ₹1,41,600
- Listing on
- NSE SME
- Exchange code
- PRAMODINI-SM · PRAMODINI
This issue combines a fresh issue and an offer for sale. The amounts for each part are not available in our data; see the offer document for the split.
Lot size and investment
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1,200 | ₹1,41,600 |
| Retail (Max) | 1 | 1,200 | ₹1,41,600 |
| HNI (Min) | 2 | 2,400 | ₹2,83,200 |
Reservation
- QIB
- 25,32,000 shares (45.91% of the Offer)
- NII
- 9,60,000 shares (17.41% of the Offer)
- Retail
- 20,23,200 shares (36.68% of the Offer)
Allotment status
The allotment for this IPO is final. Check whether you received shares on the registrar's website using your PAN, application number or demat account (DP / Client ID).
Check allotment on Purva Sharegistry (India)- 1Open the registrar's allotment page and select this IPO from the list.
- 2Enter your PAN, application number or DP / Client ID.
- 3Submit to see the number of shares allotted, if any.
- Basis of allotment
- 17 Aug 2026
- Refunds initiated
- 18 Aug 2026
- Shares credited to demat
- 18 Aug 2026
- Listing
- 19 Aug 2026
Grey market premium (GMP)
- Current GMP
- ₹0
- 0.00%
- Estimated listing price
- ₹118
- Issue price ₹118
- Highest
- ₹0
- 5 Aug
- Lowest
- ₹0
- 5 Aug
GMP by day (₹ per share)
Day-wise GMP table
| Date | GMP | Premium | Est. listing |
|---|---|---|---|
| 8 Aug 2026 | ₹0 | 0.00% | ₹118 |
| 6 Aug 2026 | ₹0 | 0.00% | ₹118 |
| 5 Aug 2026 | ₹0 | 0.00% | ₹118 |
GMP is an unofficial indicator from an unregulated market. It is shown for information only and is not a prediction of the listing price or a recommendation to apply.
Subscription status
- QIB3.66x
- NII (HNI)3.93x
- Retail3.49x
| Category | Shares offered | Shares bid for | Subscribed |
|---|---|---|---|
| Qualified Institutional Buyers (QIB) | 11,71,200 | 42,82,800 | 3.66x |
| Non-Institutional Investors (NII) | 12,96,000 | 50,95,200 | 3.93x |
| Retail Individual Investors (RII) | 20,23,200 | 70,53,600 | 3.49x |
| Total | 44,90,400 | 1,64,31,600 | 3.66x |
Financials
- P/E Ratio
- 14.97
- EPS (₹)
- 7.88
- RoCE
- 34.66%
- RoNW
- 32.69%
- PAT Margin
- 27.90%
Separate pre- and post-issue P/E are not available for this IPO; the P/E shown is as disclosed for the issue.
| Period ended | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Assets | 93.62 | 56.45 | 48.78 |
| Total Income | 63.38 | 38.55 | 35.79 |
| Profit After Tax | 17.38 | 11.14 | 7.14 |
| EBITDA | 30.90 | 20.97 | 15.53 |
| NET Worth | 53.15 | 35.77 | 24.75 |
| Reserves and Surplus | 36.46 | 34.49 | 23.46 |
| Total Borrowing | 17.85 | 10.81 | 11.96 |
Peer comparison
| Company | Issue size | P/E | RoNW | PAT margin | Subscribed | Listing gain |
|---|---|---|---|---|---|---|
| Pramodini Medicare This IPO | ₹69.04 Cr | 14.97 | 32.69% | 27.90% | 3.66x | +1.69% |
| Bio Medica Laboratories SME · listed 29 May 2026 | ₹52 Cr | 13.45 | 99.59% | 25.64% | 2.31x | -20.00% |
| Credent Connect N Care SME · listed 20 Aug 2026 | ₹93.9 Cr | 18.68 | 14.13% | 2.88% | 142.38x | +90.00% |
| ABH Healthcare SME · listed 1 Sep 2026 | ₹34.98 Cr | 20.69 | 39.07% | 10.74% | 1.42x | -2.94% |
| Avience Biomedicals SME · listed 25 Jun 2026 | ₹30.24 Cr | 16.56 | 49.89% | 15.86% | 385.4x | +90.00% |
| Speciality Medicines SME · listed 30 Mar 2026 | ₹29 Cr | 10.49 | 28.30% | 14.77% | 2.19x | 0.00% |
| Himalaya Nutravedics India SME · listed 29 Sep 2026 | ₹26.5 Cr | 12.63 | 45.12% | 17.16% | 2.24x | +11.32% |
Peers are other recent IPOs from the same industry, closest in issue size. Ratios are as disclosed at the time of each issue. This is not the listed-peer table from the offer document.
IPO objectives
How Pramodini Medicare plans to use the money raised, as stated in the offer document.
- Funding of capital expenditure for purchase of Medical Equipments towards Existing and Proposed Diagnostic Centres₹45.15 Cr
- General corporate purposes and unidentified inorganic acquisition
About Pramodini Medicare
Pramodini Medicare Limited was started in 2000. It is a diagnostic services company. It runs radiology services such as MRI, CT scan, X-ray, ultrasound with colour doppler, mammography and Dexa scan, clinical laboratory services such as pathology, microbiology, immunology and biochemistry, and nuclear medicine services such as PET-CT, SPECT and nuclear therapy. The company works through four models. Under the public private partnership model it runs diagnostic centres inside government hospitals and medical colleges on long term agreements. Under the private private model it runs centres inside private hospitals. It also works with central government PSUs, and it runs some of its own standalone centres and labs. It has a 24x7 teleradiology unit and a processing laboratory at Vijayawada. As on 4 August 2026 the company ran 16 diagnostic centres across seven states, serving government hospitals, private hospitals, PSUs, medical colleges and individual patients in Tier I, Tier II and Tier III cities. As on 31 March 2026 it had 161 permanent employees.
Strengths
- FY2026 was a strong year. Total income grew 64% from Rs 38.55 crore to Rs 63.38 crore and profit after tax grew 56% from Rs 11.14 crore to Rs 17.38 crore.
- Operating margin is high. EBITDA was Rs 30.90 crore on total income of Rs 63.38 crore in FY2026, which is close to half of the income.
- Profit has grown every year, from Rs 7.14 crore in FY2024 to Rs 11.14 crore in FY2025 and Rs 17.38 crore in FY2026.
- The PPP model with government hospitals gives long term contracts and a steady flow of patients without spending on marketing.
- The business is spread over 16 centres in seven states, so it does not depend on one city or one hospital.
- It offers radiology, laboratory and nuclear medicine together, which is a wider range than most small diagnostic chains.
- Rs 45.15 crore of the issue money is for buying medical equipment for existing and new centres, which will add earning capacity.
- Net worth improved from Rs 24.75 crore in FY2024 to Rs 53.15 crore in FY2026.
Risks
- Borrowing went up 65% in one year, from Rs 10.81 crore to Rs 17.85 crore.
- A part of the money is kept for general corporate purposes and an unidentified acquisition. The company has not named the target, so investors do not know where that money will go.
- The PPP and hospital contracts run on MOUs that come up for renewal. If a government hospital does not renew or gives the contract to another operator, that centre income stops.
- Diagnostics needs heavy spending on machines. MRI, CT and PET-CT equipment is costly and becomes outdated, so capital spending never really stops.
- A large part of the business comes from government hospitals and PSUs, where payments can be delayed and rates are fixed by tender.
- The company is small, with 161 employees and 16 centres, and competes with large national diagnostic chains that have better brand pull and lower cost per test.
- Promoter holding will come down from 85.71% to 62.64% after the issue.
- This is an SME issue. One lot is 1,200 shares, which is about Rs 1.41 lakh at the upper band of Rs 118, and SME shares usually trade in low volume after listing.
Promoters and shareholding
Chalasani Kuldeep Kumar, Chalasani Kavitha, Chalasani Durga Aashritha, Chalasani Lalithakumar and Sri Ram Medicare Pvt.Ltd
- Promoter holding, pre-issue
- 85.71%
- Promoter holding, post-issue
- 62.64%
Registrar, lead managers and documents
Lead manager
Company contact
D. No: - 29-4-54K, CSI Complex, Prakasam Road, Suryaraopet, Vijayawada, Andhra Pradesh, 520002
+91 9985782727
investors@pramodinidiagnostics.comDocuments
Pramodini Medicare IPO: common questions
1.When does the Pramodini Medicare IPO open and close?
The Pramodini Medicare IPO opens on 12 Aug 2026 and closes on 14 Aug 2026.
2.What is the price band of the Pramodini Medicare IPO?
The price band is ₹110 – ₹118 per share, with a lot size of 1,200 shares and a minimum investment of ₹1,41,600.
3.What is the size of the Pramodini Medicare IPO?
The issue size is ₹69.04 Cr (Fresh capital cum OFS).
4.What is the GMP of the Pramodini Medicare IPO?
The last reported grey market premium is ₹0 per share as of 08 Aug 2026, 02:29 PM IST. GMP is unofficial and changes frequently.
5.When is the Pramodini Medicare IPO allotment?
The basis of allotment is expected on 17 Aug 2026. Allotment status can be checked with the registrar, Purva Sharegistry (India) Private Limited.
6.When will the Pramodini Medicare IPO list?
The shares listed on 19 Aug 2026 on NSE SME.
7.Who is the lead manager of the Pramodini Medicare IPO?
The book running lead manager is Smart Horizon Capital Advisors, and the registrar is Purva Sharegistry (India) Private Limited.
8.What will the money raised in the Pramodini Medicare IPO be used for?
As stated in the offer document, the proceeds are for: Funding of capital expenditure for purchase of Medical Equipments towards Existing and Proposed Diagnostic Centres; General corporate purposes and unidentified inorganic acquisition.
9.How can my company launch an IPO like Pramodini Medicare?
Start with an IPO readiness assessment: eligibility for the NSE Emerge or BSE SME platform, audited financials, governance, conversion to a public limited company and an indicative valuation. Be IPO Ready advises promoters through each step, from readiness to listing day.
For business owners
Your company could be the next listing
Businesses like these raise growth capital on the public markets every week. Tell us about yours and our advisors will tell you, plainly, whether an IPO is within reach and what it would take.
- Eligibility check against NSE Emerge, BSE SME and Main Board norms
- Indicative valuation and issue size for your business
- A clear timeline from readiness to listing day
Check if your business can list
Fill in the eligibility form and get an assessment of where you stand. It takes about five minutes.
Prefer to talk? Call +91 92130 20393